Risk factors for severe and critically ill COVID‐19 patients: a review
Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
December 2019 form Wuhan, China leads to coronavirus disease 2019 (COVID-19) …
Increased antimicrobial resistance during the COVID-19 pandemic
In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …
SARS-CoV-2 RapidPlex: a graphene-based multiplexed telemedicine platform for rapid and low-cost COVID-19 diagnosis and monitoring
The COVID-19 pandemic is an ongoing global challenge for public health systems.
Ultrasensitive and early identification of infection is critical in preventing widespread COVID …
Ultrasensitive and early identification of infection is critical in preventing widespread COVID …
Biomarkers in COVID-19: an up-to-date review
M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis
Background and aims The ongoing COVID-19 pandemic is disproportionately affecting
patients with comorbidities. Therefore, thorough comorbidities assessment can help …
patients with comorbidities. Therefore, thorough comorbidities assessment can help …
Mucormycosis and COVID‐19: an epidemic within a pandemic in India
Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …
and increases risk of secondary infections like mucormycosis. We evaluated clinical …
I mmunosenescence and inflammaging: risk factors of severe COVID-19 in older people
Old individuals are more susceptible to various infections due to immunological changes
that occur during the aging process. These changes named collectively as …
that occur during the aging process. These changes named collectively as …
Body mass index and outcome in patients with COVID-19: a dose–response meta-analysis
Background There is mounting evidence related to the association between obesity and
severity of COVID-19. However, the direct relationship of the increase in the severe COVID …
severity of COVID-19. However, the direct relationship of the increase in the severe COVID …
IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
Abstract Aims SARS-CoV-2, an infectious agent behind the ongoing COVID-19 pandemic,
induces high levels of cytokines such as IL-1, IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ etc in …
induces high levels of cytokines such as IL-1, IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ etc in …